References
- Adeloye, D., Sowunmi, O. Y., Jacobs, W., David, R. A., Adeosun, A. A., Amuta, A. O., Chan, K. Y. (2018). Estimating the incidence of breast cancer in Africa: A systematic review and meta-analysis. Journal of Global Health, 8(1). https://doi.org/10.7189/jogh.08.010419590368229740502
- Ali, S., Mondal, N., Choudhry, H., Rasool, M., Pushparaj, P. N., Khan, M. A., Jamal, M. S. (2016). Current Management Strategies in Breast Cancer by Targeting Key Altered Molecular Players. Frontiers in Oncology, 6, 45. https://doi.org/10.3389/fonc.2016.00045477173926973813
- Aminoff, D. (1961). Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. The Biochemical Journal, 81(2), 384–392. https://doi.org/10.1042/BJ0810384
- Anderson, K. N., Schwab, R. B., & Martinez, M. E. (2014). Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Research and Treatment, 144(1),1–10. https://doi.org/101007/s10549-014-2852-710.1007/s10549-014-2852-7402619924477977
- Büll, C., Boltje, T. J., Balneger, N., Weischer, S. M., Wassink, M., Van Gemst, J. J., Adema, G. J. (2018). Sialic acid blockade suppresses tumor growth by enhancing t-cell-mediated tumor immunity. Cancer Research, 78(13), 3574–3588. https://doi.org/10.1158/0008-5472.CAN-17-337629703719
- Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009). Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis, 30(7),1073–1081. https://doi.org/10.1093/carcin/bgp12719468060
- Costa, R. L. B., & Gradishar, W. J. (2017). Triple-Negative Breast Cancer: Current Practice and Future Directions. Journal of Oncology Practice, 13(5), 301–303. https://doi.org/10.12000/JOP.2017.023333
- Dezayee, Z. M. I., & Al-Nimer, M. S. M. (2016). The clinical importance of measurement of hematological indices in the breast cancer survivals: A comparison between premenopausal and postmenopausal women. World Journal of Oncology, 7(1),1–4. https://doi.org/10.14740wjon956e10.14740/wjon956e562468128983356
- Erukainure, O. L., Zaruwa, M. Z., Choudhary, M. I., Naqvi, S. A., Ashraf, N., Hafizur, R. M., Elemo, G. N. (2016). Dietary Fatty Acids from Leaves of Clerodendrum Volubile Induce Cell Cycle Arrest, Downregulate Matrix Metalloproteinase-9 Expression, and Modulate Redox Status in Human Breast Cancer. 5581(April). https://doi.org/10.1080/01635581.2016.115671427043182
- Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Bray, F. (2015). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136(5), E359–E386. https://doi.org/10.1002/ijc.2921025220842
- Forcados, G. E., James, D. B., Sallau, A. B., Muhammad, A., & Mabeta, P. (2017). Oxidative Stress and Carcinogenesis : Potential of Phytochemicals in Breast Cancer Therapy Oxidative Stress and Carcinogenesis : Potential of Phytochemicals in Breast Cancer. Nutrition and Cancer, 69(3),365–374. https://doi.org/10.1080/01635581.2017.126777728103111
- Forcados, G. E., Sallau, A. B., Muhammad, A., Erukainure, O. L., James, D. B., & Damage, A. M. (2020). Vitex doniana Leaves Extract Ameliorates Alterations Associated with 7,12-Dimethyl Benz [ a ] Anthracene-Induced Mammary Damage in Female Wistar Rats Vitex doniana Leaves10.1080/01635581.2020.174386632223342
- Extract Ameliorates Alterations Associated with. Nutrition and Cancer, 1–15. https://doi.org/10.1080/01635581.2020.1743866
- Hayashi, N., Iwamoto, T., Qi, Y., Niikura, N., Santarpia, L., Yamauchi, H., Ueno, N. T. (2017). Bone metastasis-related signaling pathways in breast cancers stratified by estrogen receptor status. Journal of Cancer, 8(6), 1045–1052. https://doi.org/10.7150/jca.13690543625828529618
- Howlader, N., Cronin, K. A., Kurian, A. W., & Andridge, R. (2018). Differences in Breast Cancer Survival by Molecular Subtypes in the United States. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 27(6), 619–626. https://doi.org/10.1158/1055-9965.EPI-17-062729593010
- Krenn-Pilko, S., Langsenlehner, U., Stojakovic, T., Pichler, M., Gerger, A., Kapp, K. S., & Langsenlehner, T. (2016). The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients. Tumor Biology, 37(1), 361–368. https://doi.org/10.1007/s13277-015-3805-426219894
- Lee, C. L., Tsai, C. H., Yeh, D. C., Lin, C. S., Li, Y. F., & Tzeng, H. E. (2017). Hemoglobin level trajectories in the early treatment period are related with survival outcomes in patients with breast cancer. Oncotarget, 8(1), 1569–1579. https://doi.org/10.18632/oncotarget.13679535207827906669
- Mantas, D., Kostakis, I. D., Machairas, N., & Markopoulos, C. (2016). White blood cell and platelet indices as prognostic markers in patients with invasive ductal breast carcinoma. Oncology Letters, 12(2), 1610–1614. https://doi.org/10.3892/ol.2016.4760495056227446480
- Muhammad, A., Ibrahim, M. A., Erukainure, O. L., Malami, I., & Adamu, A. (2018). Spices with Breast Cancer Chemopreventive and Therapeutic Potentials: A Functional Foods Based-Review. Anti-Cancer Agents in Medicinal Chemistry, 18(2),182–194. https://doi.org/10.2174/187152061766617091212142228901261
- Muhammad, A., Ibrahim, M., Erukainure, O., Malami, I., Sani, H., & Mohammed, H. (2017). Metabolism and Toxicological Implications of Commonly Used Chemopreventive Drugs Against Breast Cancer/Carcinogenesis. Current Drug Metabolism, 17(10), 930–936. https://doi.org/10.2174/1389200218666161116121225
- Muhammad, A., Mada, S. B., Malami, I., Forcados, G. E., Erukainure, O. L., Sani, H., & Abubakar, I. B. (2018). Postmenopausal osteoporosis and breast cancer: The biochemical links and beneficial effects of functional foods. Biomedicine and Pharmacotherapy, 107(July), 571–582. https://doi.org/10.1016/j.biopha.2018.08.01830114641
- Nagasundaram, M., Horstkorte, R., & Gnanapragassam, V. S. (2020). Sialic acid metabolic engineering of breast cancer cells interferes with Adhesion and migration. Molecules,25(11). https://doi.org/10.3390/molecules25112632732119132517035
- Okuturlar, Y., Gunaldi, M., Tiken, E. E., Oztosun, B., Inan, Y. O., Ercan, T., Kumbasar, A. (2015). Utility of peripheral blood parameters in predicting breast cancer risk. Asian Pacific Journal of Cancer Prevention, 16(6), 2409–2412. https://doi.org/10.7314/APJCP.2015.16.6.2409
- Olaogun, J. G., Omotayo, J. A., Ige, J. T., Omonisi, A. E., Akute, O. O., & Aduayi, O. S. (2020). Socio-demographic, pattern of presentation and management outcome of breast cancer in a semi-urban tertiary health institution. Pan African Medical Journal, 36(363),1–10. https://doi.org/10.11604/pamj.2020.36.363.17866766668633235640
- Parise, C. A., & Caggiano, V. (2017). Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors. Breast Cancer Research and Treatment, 165(3),743–750. https://doi.org/10.1007/S10549-017-4383-528689363
- Park, B., Lee, H. S., Lee, J. W., & Park, S. (2019). Association of white blood cell count with breast cancer burden varies according to menopausal status, body mass index, and hormone receptor status: a case-control study. Scientific Reports, 9(1). https://doi.org/10.1038/s41598-019-42234-6645389030962496
- Perdicchio, M., Cornelissen, L. A. M., Streng-Ouwehand, I., Engels, S., Verstege, M. I., Boon, L., Unger, W. W. J. (2016). Tumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cells. Oncotarget, 7(8), 8771–8782. https://doi.org/10.18632/oncotarget.6822489100326741508
- Plevritis, S. K., Munoz, D., Kurian, A. W., Stout, N. K., Alagoz, O., Near, A. M., Mandelblatt, J. S. (2018). Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012. JAMA, 319(2), 154–164. https://doi.org/10.1001/JAMA.2017.19130583365829318276
- Prat, A., Pineda, E., Adamo, B., Galván, P., Fernández, A., Gaba, L., Muñoz, M. (2015). Clinical implications of the intrinsic molecular subtypes of breast cancer. The Breast, 24,S26–S35. https://doi.org/10.1016/j.breast.2015.07.00826253814
- Qian, F., Ogundiran, T., Hou, N., Ndom, P., Gakwaya, A., Jombwe, J., Huo, D. (2014). Alcohol consumption and breast cancer risk among women in three sub-saharan african countries. PLoS ONE, 9(9). https://doi.org/10.1371/journal.pone.0106908415784625198723
- Raza, U., Sheikh, A., Jamali, S. N., Turab, M., Zaidi, S. A., & Jawaid, H. (2020). Post-treatment Hematological Variations and the Role of Hemoglobin as a Predictor of Disease-free Survival in Stage 2 Breast Cancer Patients. Cureus, 12(3). https://doi.org/10.7759/cureus.7259715257732292672
- Reed, H. E., & Mberu, B. U. (2015). Benefits and Diminishing the Burdens. 27(2), 319–330. https://doi.org/10.11564/27-2-477.Capitalizing
- Seiler, A., Chen, M. A., Brown, R. L., & Fagundes, C. P. (2018). Obesity, Dietary Factors, Nutrition, and Breast Cancer Risk. Current Breast Cancer Reports, Vol. 10. https://doi.org/10.1007/s12609-018-0264-0633504630662586
- Sharma, P. (2016). Biology and Management of Patients With Triple-Negative Breast Cancer. The Oncologist, 21(9), 1050–1062. https://doi.org/10.1634/THEONCOLOGIST.2016-0067501607127401886
- Shimelis, H., LaDuca, H., Hu, C., Hart, S. N., Na, J., Thomas, A., Couch, F. J. (2018). Triple-negative breast cancer risk genes identified by multigene hereditary cancer panel testing. Journal of the National Cancer Institute, 110(8), 855–862. https://doi.org/10.1093/jnci/djy106609335030099541
- Suleiman, R. B., Muhammad, A., Umara, I. A., Ibrahima, M. A., Erukainure, O. L., Forcados, G. E., & Katsayal, S. B. (2021). Kolaviron Ameliorates 7, 12-Dimethylbenzanthracene - Induced Mammary Damage in Female10.2174/187152062166621032210123234225638
- Wistar Rats. Anti-Cancer Agents in Medicinal Chemistry, 21. https://doi.org/10.2174/1871520621666210322101232
- Teoh, S. T., Ogrodzinski, M. P., Ross, C., Hunter, K. W., & Lunt, S. Y. (2018). Sialic acid metabolism: A key player in breast cancer metastasis revealed by metabolomics. Frontiers in Oncology, 8(MAY), 174. https://doi.org/10.3389/fonc.2018.00174598544929892572
- Vogel, V.G. (2017). Epidemiology of breast cancer. In The Breast: Comprehensive Management of Benign and Malignant Diseases. https://di.org/10.1016/B978-0-323-35955-9.00015-5
- Yang, X., Wang, H., & Jiao, B. (2017). Mammary gland stem cells and their application in breast cancer. Oncotarget, 8(6), 10675–10691. https://doi.org/10.18632/oncotarget.12893535469127793013
- Yedjou, C. G., Sims, J. N., Miele, L., Noubissi, F., Lowe, L., Fonseca, D. D., Tchounwou, P. B. (2019). Health and Racial Disparity in Breast Cancer. In Advances in Experimental Medicine and Biology (Vol. 1152, pp. 31–49). https://doi.org/10.1007/978-3-030-20301-6_3694114731456178
- Zhu, J., Jiao, D., Zhao, Y., Guo, X., Yang, Y., Xiao, H., & Liu, Z. (2021). Development of a predictive model utilizing the neutrophil to lymphocyte ratio to predict neoadjuvant chemotherapy efficacy in early breast cancer patients. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-020-80037-2780901933446717